Overview of Dr. Morris
Dr. Luc Morris is an otolaryngologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 13 years. He is one of 21 doctors at Memorial Sloan Kettering Cancer Center who specialize in Otolaryngology (ENT). He has more than 100 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2009 - 2011
- Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2007 - 2010
- NYU Grossman School of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2005 - 2009
- NYU Grossman School of MedicineInternship, Surgery, 2004 - 2005
- New York University School of MedicineClass of 2004
- Columbia UniversityMSc
- Brown UniversityScB
Certifications & Licensure
- NY State Medical License 2007 - 2026
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
Publications & Presentations
PubMed
- Impact of Surveillance Imaging in Patients With HPV-Associated Oropharyngeal Carcinoma Treated With Definitive Radiation and Chemotherapy.Trisha Shang, Gabriel Raab, Linda Chen, Yao Yu, Achraff Shamseddine
American Journal of Clinical Oncology. 2025-01-01 - Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.Antoine Desilets, Joris L Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem
Clinical Cancer Research. 2024-12-02 - Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines.Joyce Lee, Lynn K Han, Luc G T Morris, Deborah Korenstein, Jennifer L Marti
Journal of Medical Screening. 2024-12-01
Press Mentions
- Papillary Thyroid Cancer: Is Surgical Operation Constantly Vital?July 1st, 2021
- Cancer-Specific TMB Cutoffs May Help Guide ICI UseJune 19th, 2020
- Immune-Related Toxicities Signal Improved ICI Efficacy in People with Cancer, Autoimmune DiseaseDecember 8th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: